- Published on 07 May 2019
Johannesburg, Tuesday 7 May 2019. Northam shareholders are advised that Dr NY (Yoza) Jekwa and Mr JJ (Jean) Nel have been appointed to the company’s audit and risk committee with effect from 1 June 2019. Both currently serve on the board as independent, non-executive directors.
Yoza Jekwa has served on the Northam board since 8 November 2017. She is also an independent non-executive director of Ascendis Health Limited. Dr Jekwa holds an MBA in Finance and an MBBCh (Bachelor of Medicine and Bachelor of Surgery). She has extensive experience in the South African corporate banking industry and has held various positions in the medical field in South Africa and the United Kingdom.
Jean Nel was appointed to the Northam board on 6 November 2018. He is a non-executive director of Mimosa Holdings (Pvt) Limited, Mimosa Investment Limited and DRDGOLD Limited. Mr Nel qualified as a chartered accountant and has more than 18 years’ experience in mining and mining finance. Mr Nel held the position of CEO for the PGM division of Sibanye-Stillwater Limited following that company’s acquisition of Aquarius Platinum Limited (Aquarius) in 2016. He was previously CEO of Aquarius.
Dr Jekwa and Mr Nel will replace Ms TE (Emily) Kgosi and Mr R (Ralph) Havenstein on the audit and risk committee. The audit and risk committee will comprise the following members, all of whom are non-executive and independent: Ms Hester Hickey (chairman); Mr David Brown; Dr Yoza Jekwa and Mr Jean Nel.
This announcement is made in compliance with paragraph 3.59 of the JSE Listings Requirements, and follows on the recommendations of the Northam nomination committee.
The members of the board would like to express their appreciation to Emily Kgosi and Ralph Havenstein for their service to the committee. They will both continue to serve the company as independent non-executive directors.
R&A Strategic Communications
Tel +27 (0)11 880 3924
+27 71 493 0387